NCT06511141 2026-03-12
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Axonics, Inc.
Phase NA Recruiting
Clinical Trials
39 trialsNCT04879940 2026-02-05
Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Recruiting
NCT06051942 2026-01-28
PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs
PROCEPT BioRobotics
Phase NA Active not recruiting
NCT05148156 2026-01-27
Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer.
Northwell Health
Phase NA Suspended
NCT06161506 2025-12-23
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
NCT07071207 2025-11-06
TextMsgM-ISI
University of Rochester
Phase NA Recruiting
NCT07115992 2025-08-26
PRESEL
Ruijin Hospital
Phase NA Recruiting
NCT04853914 2025-06-05
Evaluation of the Safety of the Treatment of Benign Prostatic Hyperplasia by High Intensity Focused Ultrasound.
EDAP TMS S.A.
Phase NA Completed
NCT06820502 2025-02-11
OUTCOMES of SIMULTANEOUS TRANSURETHRAL PROSTATE and BLADDER TUMOR RESECTION VERSUS TRANSURETHRAL BLADDER TUMOR RESECTION in BLADDER TUMOR with BLADDER PROSTATE HYPERPLASIA
Allama Iqbal Medical College
Phase NA Active not recruiting
NCT03350529 2024-11-25
HIFU-PRO
Turku University Hospital
Phase NA Completed
NCT04693507 2024-07-23
TEACh
Antev Ltd.
Phase 2 Completed
NCT06001619 2023-08-21
PROMED
Turku University Hospital
Phase 4 Recruiting
NCT05851521 2023-05-09
HERMES
Lyx Institute
Phase NA Unknown
NCT05834270 2023-04-28
Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH
Menoufia University
Phase NA Completed
NCT04446429 2021-12-10
Anti-Androgen Treatment for COVID-19
Applied Biology, Inc.
Phase NA Completed
NCT03064282 2021-02-25
Prostatic Hyperplasia Treatment and Cancer Prevention
Manchanda Medical Clinic
Phase EARLY_PHASE1 Unknown
NCT01194960 2020-10-19
TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)
Oxford BioMedica
Phase 2 Terminated
NCT04212403 2020-02-24
Prophylaxis001
Jessa Hospital
Phase NA Completed
NCT04108871 2019-09-30
Whether Transperineal Prostate Biopsy Under Local-anaesthesia Using a Transperineal-access System is Non-inferior to Standard Transrectal Biopsy to Detect Prostate Cancer in Biopsy-naïve Men
The University of Hong Kong
Phase NA Unknown
NCT03600766 2019-09-04
Mirabegron for Treatment of Erectile Dysfunction in Patients With LUTS Secondry to BPH: A Randomized Study
Mansoura University
Phase 2 Unknown
NCT03831321 2019-02-05
The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy
Istanbul Medeniyet University
Phase 4 Unknown
NCT02916537 2017-11-06
A Phase 1 Trial for Evaluation of the Safety, Pharmacokinetics, and [18F] Radiation Dosimetry of CTT1057
Cancer Targeted Technology
Phase 1 Completed
NCT02167919 2017-09-14
Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH)
University of North Carolina, Chapel Hill
Phase NA Completed
NCT02778243 2017-06-14
STERPROSER
Hopital Foch
Phase NA Completed
NCT00375765 2017-01-19
Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer
GlaxoSmithKline
Phase 4 Completed
NCT02846467 2016-08-10
Information Improvement for Surgical Patients Through Portable Video Media
Hospital Universitario Puerto Real
Phase NA Completed
NCT02015806 2016-01-11
REMIND
Brigham and Women's Hospital
Phase NA Completed
NCT02496442 2015-07-14
Aqueduct Irrigation System Clinical Protocol: Medical Device Investigational Plan
Flowmed
Phase NA Unknown
NCT01520441 2015-06-03
BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH)
The University of Texas Health Science Center, Houston
Phase EARLY_PHASE1 Withdrawn
NCT01177436 2014-08-29
Prostate Cancer Antigen 3 (PCA-3) Gene Project
Assistance Publique Hopitaux De Marseille
Phase NA Completed
NCT01665586 2014-07-28
Effective Dose of Dexmedetomidine for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia With or Without Fentanyl by Age Groups: Randomized Comparative Study
Yonsei University
Phase NA Completed
NCT01678313 2014-07-15
Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels
Buddhist Tzu Chi General Hospital
Phase 2 Completed
NCT00706966 2014-01-17
MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer
University of California, San Francisco
Phase NA Completed
NCT00416390 2013-09-20
Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic Hyperplasia
National Cancer Institute (NCI)
Phase NA Completed
NCT00632138 2013-08-07
Pelvic Floor Muscle Training and Biofeedback or Standard Therapy in Men Who Have Undergone Radical Prostatectomy or Transurethral Resection of the Prostate
National Cancer Institute (NCI)
Phase 3 Completed
NCT01876836 2013-06-13
C-LMA
Diskapi Yildirim Beyazit Education and Research Hospital
Phase 4 Unknown
NCT01218243 2013-05-27
An Efficacy Trial of Electroacupuncture at Points of Bilateral BL33 for Mild and Moderate Benign Prostatic Hyperplasia
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Phase 2 Completed
NCT00426777 2012-02-03
Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer
CMX Research
Phase 3 Completed
NCT01314456 2011-03-16
3D Recording of a Trans-rectal Prostate Biopsy
HaEmek Medical Center, Israel
Phase NA Unknown